Literature DB >> 14638769

The site of Leishmania major infection determines disease severity and immune responses.

Tracey M Baldwin1, Colleen Elso, Joan Curtis, Lynn Buckingham, Emanuela Handman.   

Abstract

Inbred strains of mice infected with Leishmania major have been classified as genetically resistant or susceptible on the basis of their ability to cure their lesions, the parasite burden in the draining lymph nodes, and their type of T helper cell immune responses to the parasite. Using the intradermal infection at the base of the tail and the ear pinna, we compared for the first time the above-mentioned parameters in six strains of mice infected with metacyclic promastigotes, and we show that the severity of disease depends greatly on the site of infection. Although the well-documented pattern of disease susceptibility of BALB/c and C57BL/6 mice described for the footpad and base-of-the-tail models of leishmaniasis were confirmed, C3H/HeN and DBA/2 mice, which are intermediate and susceptible, respectively, in the tail and other models, were resistant to ear infection. Moreover, in the CBA/H, C3H/HeN, C57BL/6J, and DBA/2 mouse strains, there was little correlation between the pattern of cytokines produced and the disease phenotype observed at the ear and tail sites. We conclude that the definition of susceptibility and the immune mechanisms leading to susceptibility or resistance to infection may differ substantially depending on the route of infection.

Entities:  

Mesh:

Year:  2003        PMID: 14638769      PMCID: PMC308923          DOI: 10.1128/IAI.71.12.6830-6834.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  The host response to Leishmania infection.

Authors:  W Solbach; T Laskay
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

Authors:  Y Belkaid; S Mendez; R Lira; N Kadambi; G Milon; D Sacks
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.

Authors:  T Biedermann; S Zimmermann; H Himmelrich; A Gumy; O Egeter; A K Sakrauski; I Seegmüller; H Voigt; P Launois; A D Levine; H Wagner; K Heeg; J A Louis; M Röcken
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

4.  Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway.

Authors:  C M Elso; L J Roberts; G K Smyth; R J Thomson; T M Baldwin; S J Foote; E Handman
Journal:  Genes Immun       Date:  2004-03       Impact factor: 2.676

5.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 6.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 7.  The present and future of vaccination for cutaneous leishmaniasis.

Authors:  C L Greenblatt
Journal:  Prog Clin Biol Res       Date:  1980

8.  Racial differences in espundia.

Authors:  B C Walton; L Valverde
Journal:  Ann Trop Med Parasitol       Date:  1979-02

Review 9.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

10.  Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.

Authors:  P M Preston; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

View more
  22 in total

1.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

3.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

4.  Evaluation of s.c. route of immunization by homologous radio attenuated live vaccine in experimental murine model of visceral leishmaniasis.

Authors:  Sanchita Datta; Supriya Khanra; Anindita Chakraborty; Syamal Roy; Madhumita Manna
Journal:  J Parasit Dis       Date:  2014-09-20

5.  Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.

Authors:  Khaled S Tabbara; Nathan C Peters; Farhat Afrin; Susana Mendez; Sylvie Bertholet; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse ear.

Authors:  Malcolm S Duthie; Stephen T Reece; Ramanuj Lahiri; Wakako Goto; Vanitha S Raman; Juliette Kaplan; Greg C Ireton; Sylvie Bertholet; Thomas P Gillis; James L Krahenbuhl; Steven G Reed
Journal:  Infect Immun       Date:  2007-08-27       Impact factor: 3.441

7.  Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice.

Authors:  Cristina R Carter; James P Whitcomb; Jessica A Campbell; Rami M Mukbel; Mary Ann McDowell
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

8.  Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes.

Authors:  Tracey Baldwin; Sandrine Henri; Joan Curtis; Meredith O'Keeffe; David Vremec; Ken Shortman; Emanuela Handman
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection.

Authors:  Claudia Gonzalez-Lombana; Ciara Gimblet; Olivia Bacellar; Walker W Oliveira; Sara Passos; Lucas P Carvalho; Michael Goldschmidt; Edgar M Carvalho; Phillip Scott
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

10.  The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Ghader Khalili; Firoozeh Abrishami; Ali Najafy; Vahid Khaze
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.